Galderma surges in debut, bolstering Europe IPO recovery
The EQT AB-backed company climbed as much as 18% to 62.68 francs in Zurich on Friday. It priced its CHF 2.3bn (USD 2.6bn) initial public offering (IPO) at 53 francs share, the top end of a marketed range.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Media: Private equity firm prepares Galderma IPO
For subscribers